Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Follow-Up Questions
Quel est le ratio P/E de Labcorp Holdings Inc (LH) ?
Le ratio P/E de Labcorp Holdings Inc est de 31.1658
Qui est le CEO de Labcorp Holdings Inc ?
Mr. Adam Schechter est le Chairman of the Board de Labcorp Holdings Inc, il a rejoint l'entreprise depuis 2013.
Quelle est la performance du prix de l'action LH ?
Le prix actuel de LH est de $252.33, il a increased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Labcorp Holdings Inc ?
Labcorp Holdings Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Labcorp Holdings Inc ?
La capitalisation boursière actuelle de Labcorp Holdings Inc est de $20.9B
Est-ce que Labcorp Holdings Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 22 analystes ont établi des notations d'analystes pour Labcorp Holdings Inc, y compris 10 achat fort, 14 achat, 5 maintien, 0 vente et 10 vente forte
